MapLight Therapeutics
MPLT
Insider trades and stock quote 2024-2026
All insider trades at MapLight Therapeutics
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
8/3/2026
|
Sell |
Lillie, James Woodruff |
Chief Scientific Officer |
$12.5 |
$276,908 |
|
7/28/2026
|
Buy |
Cox, Troy |
Director |
$9.5 |
$148,702 |
|
7/17/2026
|
Sell |
Kroeger, Christopher A. |
Chief Executive Officer |
$37.9 |
$635,924 |
|
7/17/2026
|
Sell |
Gillis, Jonathan |
CAO and Interim CFO |
$37.4 |
$694,463 |
|
7/17/2026
|
Sell |
Lillie, James Woodruff |
Chief Scientific Officer |
$37.9 |
$78,718 |
|
7/17/2026
|
Sell |
Hanson, Kristopher |
General Counsel |
$37.9 |
$42,827 |
|
7/17/2026
|
Sell |
Foff, Erin Pennock |
Chief Medical Officer |
$37.9 |
$138,562 |
|
7/17/2026
|
Sell |
Kreitzer, Anatol |
Chief Discovery Officer |
$37.7 |
$645,719 |
|
7/16/2026
|
Sell |
Kroeger, Christopher A. |
Chief Executive Officer |
$37.2 |
$2,541,341 |
|
7/16/2026
|
Sell |
Gillis, Jonathan |
CAO and Interim CFO |
$37.0 |
$311,111 |
|
7/16/2026
|
Sell |
Lillie, James Woodruff |
Chief Scientific Officer |
$37.2 |
$314,413 |
|
7/16/2026
|
Sell |
Hanson, Kristopher |
General Counsel |
$37.2 |
$298,616 |
|
7/16/2026
|
Sell |
Foff, Erin Pennock |
Chief Medical Officer |
$37.2 |
$553,334 |
|
7/16/2026
|
Sell |
Kreitzer, Anatol |
Chief Discovery Officer |
$37.0 |
$333,234 |
|
7/15/2026
|
Sell |
Kroeger, Christopher A. |
Chief Executive Officer |
$36.8 |
$2,266,458 |
|
7/15/2026
|
Sell |
Gillis, Jonathan |
CAO and Interim CFO |
$36.5 |
$367,093 |
|
7/15/2026
|
Sell |
Lillie, James Woodruff |
Chief Scientific Officer |
$36.8 |
$280,505 |
|
7/15/2026
|
Sell |
Hanson, Kristopher |
General Counsel |
$36.8 |
$266,427 |
|
7/15/2026
|
Sell |
Foff, Erin Pennock |
Chief Medical Officer |
$36.8 |
$1,042,594 |
|
7/15/2026
|
Sell |
Kreitzer, Anatol |
Chief Discovery Officer |
$36.5 |
$366,940 |
|
5/18/2026
|
Sell |
Kroeger, Christopher A. |
Chief Executive Officer |
$27.7 |
$3,215,000 |
|
5/11/2026
|
Sell |
Kroeger, Christopher A. |
Chief Executive Officer |
$29.2 |
$421,002 |
|
5/11/2026
|
Sell |
Hanson, Kristopher |
General Counsel |
$29.2 |
$419,262 |
|
5/8/2026
|
Sell |
Kroeger, Christopher A. |
Chief Executive Officer |
$28.4 |
$952,836 |
|
5/7/2026
|
Sell |
Kroeger, Christopher A. |
Chief Executive Officer |
$28.8 |
$575,797 |
|
5/7/2026
|
Sell |
Lillie, James Woodruff |
Chief Scientific Officer |
$28.3 |
$20,390 |
|
5/7/2026
|
Sell |
Foff, Erin Pennock |
Chief Medical Officer |
$28.8 |
$126,640 |
|
5/6/2026
|
Sell |
Kroeger, Christopher A. |
Chief Executive Officer |
$28.6 |
$681,583 |
|
5/6/2026
|
Sell |
Lillie, James Woodruff |
Chief Scientific Officer |
$28.6 |
$713,600 |
|
5/6/2026
|
Sell |
Foff, Erin Pennock |
Chief Medical Officer |
$28.6 |
$691,749 |
|
5/6/2026
|
Sell |
Setia, Vishwas |
Chief Financial Officer |
$28.6 |
$298,345 |
|
5/5/2026
|
Sell |
Kroeger, Christopher A. |
Chief Executive Officer |
$28.6 |
$295,289 |
|
5/5/2026
|
Sell |
Lillie, James Woodruff |
Chief Scientific Officer |
$28.6 |
$312,839 |
|
5/5/2026
|
Sell |
Foff, Erin Pennock |
Chief Medical Officer |
$28.6 |
$298,216 |
|
5/5/2026
|
Sell |
Setia, Vishwas |
Chief Financial Officer |
$28.6 |
$307,444 |
|
5/4/2026
|
Sell |
Kroeger, Christopher A. |
Chief Executive Officer |
$28.9 |
$435,363 |
|
5/4/2026
|
Sell |
Lillie, James Woodruff |
Chief Scientific Officer |
$28.9 |
$441,813 |
|
5/4/2026
|
Sell |
Hanson, Kristopher |
General Counsel |
$28.9 |
$388,177 |
|
5/4/2026
|
Sell |
Foff, Erin Pennock |
Chief Medical Officer |
$28.9 |
$437,629 |
|
5/4/2026
|
Sell |
Setia, Vishwas |
Chief Financial Officer |
$28.8 |
$418,930 |
|
4/28/2026
|
Sell |
Gillis, Jonathan |
CAAO and PAO |
$30.6 |
$544,319 |
|
4/27/2026
|
Sell |
Gillis, Jonathan |
CAAO and PAO |
$29.7 |
$1,543,369 |
|
4/27/2026
|
Sell |
Kreitzer, Anatol |
Chief Discovery Officer |
$29.7 |
$1,347,067 |
|
4/16/2026
|
Sell |
Kroeger, Christopher A. |
Chief Executive Officer |
$27.2 |
$275,141 |
|
4/16/2026
|
Sell |
Lillie, James Woodruff |
Chief Scientific Officer |
$27.2 |
$76,176 |
|
4/16/2026
|
Sell |
Hanson, Kristopher |
General Counsel |
$27.2 |
$8,157 |
|
4/16/2026
|
Sell |
Foff, Erin Pennock |
Chief Medical Officer |
$27.2 |
$31,998 |
|
4/16/2026
|
Sell |
Setia, Vishwas |
Chief Financial Officer |
$27.2 |
$3,175 |
|
4/15/2026
|
Sell |
Kroeger, Christopher A. |
Chief Executive Officer |
$26.9 |
$246,006 |
|
4/15/2026
|
Sell |
Gillis, Jonathan |
CAAO and PAO |
$26.6 |
$95,530 |
|
4/15/2026
|
Sell |
Lillie, James Woodruff |
Chief Scientific Officer |
$26.8 |
$46,399 |
|
4/15/2026
|
Sell |
Hanson, Kristopher |
General Counsel |
$26.8 |
$40,977 |
|
4/15/2026
|
Sell |
Malenka, Robert C. |
Director |
$26.9 |
$231,152 |
|
4/15/2026
|
Sell |
Foff, Erin Pennock |
Chief Medical Officer |
$26.8 |
$54,861 |
|
4/15/2026
|
Sell |
Kreitzer, Anatol |
Chief Discovery Officer |
$26.6 |
$88,239 |
|
4/15/2026
|
Sell |
Setia, Vishwas |
Chief Financial Officer |
$26.9 |
$75,397 |
|
2/24/2026
|
Sell |
Malenka, Robert C. |
Director |
$18.2 |
$13,358 |
|
2/23/2026
|
Sell |
Malenka, Robert C. |
Director |
$18.7 |
$207,464 |
|
2/20/2026
|
Buy |
Pavlov, George |
Director |
$17.9 |
$177,171 |
|
2/20/2026
|
Sell |
Malenka, Robert C. |
Director |
$18.0 |
$39,576 |
|
2/19/2026
|
Buy |
Pavlov, George |
Director |
$17.6 |
$77,695 |
|
2/18/2026
|
Buy |
Pavlov, George |
Director |
$17.5 |
$186,302 |
|
2/13/2026
|
Sell |
Malenka, Robert C. |
Director |
$18.2 |
$220,632 |
|
2/11/2026
|
Sell |
Malenka, Robert C. |
Director |
$18.0 |
$4,338 |
|
2/10/2026
|
Buy |
Garnett, Timothy John |
Director |
$17.9 |
$252,678 |
|
2/10/2026
|
Sell |
Malenka, Robert C. |
Director |
$18.1 |
$119,991 |
|
2/3/2026
|
Sell |
Malenka, Robert C. |
Director |
$18.0 |
$18 |
|
2/2/2026
|
Sell |
Malenka, Robert C. |
Director |
$18.0 |
$126,843 |
|
1/30/2026
|
Sell |
Malenka, Robert C. |
Director |
$18.1 |
$119,743 |
|
1/29/2026
|
Sell |
Malenka, Robert C. |
Director |
$18.6 |
$394,410 |
|
1/28/2026
|
Sell |
Malenka, Robert C. |
Director |
$18.8 |
$121,704 |
|
10/28/2025
|
Buy |
Novo, Holdings A. |
Ten Percent Owner |
$17.0 |
$16,199,997 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Free Updates via Email
Please confirm your email address